Pfizer Inc. reports its Q2 earnings soon, carrying the weight of a 10% stock dip this year. The company, known for its ...

Bristol Myers Squibb offers a 5.6% dividend yield, strong cash flow, and AI-driven growth potential. See why I see this as a ...

Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing model for ...

President Trump discusses plans to dramatically cut drug prices, matching the lowest rates worldwide and promising ...

Thousands of Medicare recipients will face higher costs for expensive cancer drugs following passage of two provisions in the One Big Beautiful Bill Act, signed by President Donald Trump in July, The ...

"We've cut drug prices by 1,200, 1,300, 1,400, 1,500 percent. I don't mean 50 percent. I mean 14-, 1,500 percent," Trump said ...

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

Little-known provisions in the Big Beautiful Bill lobbied by industry will cost Medicare billions in missed savings.

President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to the artificially low, government-set prices in other developed nati… ...

President Trump recently issued an executive order, aiming to lower prescription costs down for Americans by aligning prices with those paid in other wealthy nations. The policy introduces a ...

Prescription Drug Affordability Boards (PDABs) are becoming a larger part of the state drug price regulatory landscape. 1 The boards are regulatory bodies that review the affordability and cost of ...